API0232950

Troglitazone

Troglitazone is a PPARγ agonist, withdrawn from market, formerly used for diabetes.

Product Size

Quantity

Pharm Gradet

Standard

Registration

Inquiry

API Description

API Details

Document

Related Patent Status

Molecular Weight (g/mol)

441.5
Molecular Formula

C24H27NO5S
InChI

InChI=1S/C24H27NO5S/c1-13-14(2)21-18(15(3)20(13)26)9-10-24(4,30-21)12-29-17-7-5-16(6-8-17)11-19-22(27)25-23(28)31-19/h5-8,19,26H,9-12H2,1-4H3,(H,25,27,28)
InChIKey

GXPHKUHSUJUWKP-UHFFFAOYSA-N
SMILES

CC1=C(C2=C(CCC(O2)(C)COC3=CC=C(C=C3)CC4C(=O)NC(=O)S4)C(=C1O)C)C
IUPAC Name

5-[[4-[(6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydrochromen-2-yl)methoxy]phenyl]methyl]-1,3-thiazolidine-2,4-dione
Exact Mass (Da)

441.16099414
Monoisotopic Mass (Da)

441.16099414

OUR PRODUCTS